Related Experiment Videos

mu-Opioid receptor-mediated reduction of neuronal calcium current occurs via a G(o)-type GTP-binding protein

H C Moises1, K I Rusin, R L Macdonald

  • 1Department of Physiology, University of Michigan, Ann Arbor 48109-0622.

Insights

Mu-opioid receptors inhibit calcium channels in rat neurons via G-proteins. This study shows the G(o) protein subtype mediates this effect, independent of adenylate cyclase activity, offering insights into pain signaling.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Molecular Biology

Background:

  • Mu-opioid receptor activation inhibits calcium channel currents in rat dorsal root ganglion (DRG) neurons.
  • The precise G-protein pathway linking mu-opioid receptors to calcium channels, and its relation to adenylate cyclase activity, remains unclear.

Purpose of the Study:

  • To investigate the role of G-proteins in mediating mu-opioid receptor-induced inhibition of calcium channel activity in rat DRG neurons.
  • To determine if changes in adenylate cyclase activity are involved in this inhibitory pathway.

Main Methods:

  • Whole-cell recordings were performed on acutely isolated rat DRG neurons.
  • Neurons were treated with pertussis toxin (PTX) or dialyzed with guanosine 5'-[-thio]triphosphate (GTPγS) and specific G-protein antisera (anti-G(o) and anti-Gi).
  • The effect of a mu-opioid agonist (PLO17) on calcium currents was assessed under these conditions.

Main Results:

  • Mu-opioid agonist-induced inhibition of calcium current was blocked by PTX pretreatment and mimicked/irreversibilized by GTPγS.
  • Inclusion of the cAMP-dependent protein kinase catalytic subunit did not affect the inhibitory response to the mu-opioid agonist.
  • Antisera specific for G(o)alpha subunits significantly attenuated the inhibitory effect, while anti-Gi antisera did not.

Conclusions:

  • Mu-opioid receptor-mediated inhibition of calcium channels in rat DRG neurons involves the activation of PTX-sensitive G-proteins.
  • The G(o) subclass of GTP-binding proteins, not Gi, appears to be the primary mediator of this signaling pathway.
  • This inhibition occurs independently of alterations in adenylate cyclase activity.

Related Concept Videos